|
humans |
147 |
|
female |
124 |
|
adult |
95 |
|
pregnancy |
94 |
|
male |
80 |
|
animals |
71 |
|
middle aged |
67 |
|
chinese |
54 |
|
molecular sequence data |
46 |
|
aged |
45 |
|
apoptosis |
44 |
|
adolescent |
40 |
|
ovarian cancer |
40 |
|
reverse transcriptase polymerase chain reaction |
39 |
|
cervical cancer |
37 |
|
immunohistochemistry |
37 |
|
mice |
33 |
|
prognosis |
32 |
|
base sequence |
30 |
|
cell line |
30 |
|
cohort studies |
30 |
|
infertility |
30 |
|
genotype |
29 |
|
hong kong |
29 |
|
in vitro fertilization |
29 |
|
cell proliferation |
28 |
|
china |
28 |
|
case-control studies |
27 |
|
risk factors |
27 |
|
aged, 80 and over |
26 |
|
amino acid sequence |
26 |
|
polymerase chain reaction |
26 |
|
sensitivity and specificity |
26 |
|
blotting, western |
25 |
|
cricetinae |
25 |
|
chemotherapy |
24 |
|
endometrium |
24 |
|
hong kong - epidemiology |
24 |
|
medical sciences |
24 |
|
time factors |
24 |
|
asian continental ancestry group - genetics |
23 |
|
cells, cultured |
23 |
|
fallopian tube |
23 |
|
gene expression regulation, neoplastic |
23 |
|
gestational age |
23 |
|
homozygote |
23 |
|
human papillomavirus |
23 |
|
breast cancer |
22 |
|
cell line, tumor |
22 |
|
genetic predisposition to disease |
22 |
|
gestational trophoblastic disease |
22 |
|
ivf |
22 |
|
retrospective studies |
22 |
|
asian continental ancestry group |
21 |
|
choriocarcinoma |
21 |
|
dna methylation |
21 |
|
placenta |
21 |
|
prospective studies |
21 |
|
vitamin d |
21 |
|
gestational trophoblastic neoplasia |
20 |
|
pregnancy outcome |
20 |
|
prenatal diagnosis |
20 |
|
screening |
20 |
|
sequence analysis, dna |
20 |
|
diagnosis, differential |
19 |
|
embryo implantation |
19 |
|
gene expression profiling |
19 |
|
hysterectomy |
19 |
|
implantation |
19 |
|
oncology |
19 |
|
predictive value of tests |
19 |
|
rats |
19 |
|
dna mutational analysis |
18 |
|
ectopic pregnancy |
18 |
|
mutation - genetics |
18 |
|
osteoporosis |
18 |
|
polycystic ovary syndrome |
18 |
|
polymorphism, single nucleotide - genetics |
18 |
|
prevalence |
18 |
|
quality of life |
18 |
|
ultrasound |
18 |
|
cancer |
17 |
|
follow-up studies |
17 |
|
human spermatozoa |
17 |
|
infant |
17 |
|
laparoscopy |
17 |
|
mutation |
17 |
|
progesterone |
17 |
|
spermatogenesis |
17 |
|
transfection |
17 |
|
uterus |
17 |
|
cercopithecus aethiops |
16 |
|
cervical screening |
16 |
|
endometrial receptivity |
16 |
|
fertilization |
16 |
|
gene expression |
16 |
|
neoplasm staging |
16 |
|
rna, messenger - metabolism |
16 |
|
trophoblast |
16 |
|
alleles |
15 |
|
china - ethnology |
15 |
|
chinese women |
15 |
|
dose-response relationship, drug |
15 |
|
hydatidiform mole |
15 |
|
intravoxel incoherent motion |
15 |
|
membrane proteins - genetics - metabolism |
15 |
|
mifepristone |
15 |
|
misoprostol |
15 |
|
ovarian response |
15 |
|
ovary |
15 |
|
promoter regions, genetic |
15 |
|
promoter regions, genetic - genetics |
15 |
|
testis |
15 |
|
tumor cells, cultured |
15 |
|
acrosome reaction |
14 |
|
anti-müllerian hormone |
14 |
|
cell line, transformed |
14 |
|
cricetulus |
14 |
|
frozen embryo transfer |
14 |
|
gene frequency |
14 |
|
in situ hybridization |
14 |
|
invasion |
14 |
|
menopause |
14 |
|
obesity |
14 |
|
oviduct |
14 |
|
ovulation induction |
14 |
|
oxidative stress |
14 |
|
polymerase chain reaction - methods |
14 |
|
signal transduction |
14 |
|
signal transduction - physiology |
14 |
|
spermatozoa |
14 |
|
tubal ectopic pregnancy |
14 |
|
zona pellucida |
14 |
|
adrenomedullin |
13 |
|
anti-mullerian hormone |
13 |
|
antigens, cd - genetics |
13 |
|
biopsy |
13 |
|
cell adhesion molecules - genetics |
13 |
|
cell cycle |
13 |
|
embryo |
13 |
|
extracellular vesicles |
13 |
|
fertilization in vitro |
13 |
|
first trimester |
13 |
|
genes, tumor suppressor |
13 |
|
granulosa cells |
13 |
|
infant, newborn |
13 |
|
karyotyping |
13 |
|
l-lactate dehydrogenase - blood |
13 |
|
microrna |
13 |
|
miscarriage |
13 |
|
neoplasm invasiveness |
13 |
|
obstetrics and gynecology |
13 |
|
polymorphism, single nucleotide |
13 |
|
pregnancy rate |
13 |
|
pregnancy trimester, first |
13 |
|
proliferation |
13 |
|
proteins - metabolism |
13 |
|
rats, sprague-dawley |
13 |
|
sperm |
13 |
|
transcription, genetic |
13 |
|
ultrasonography |
13 |
|
antral follicle count |
12 |
|
biology |
12 |
|
cancer survivors |
12 |
|
cell proliferation - drug effects |
12 |
|
cervical cancer screening |
12 |
|
cervical intraepithelial neoplasia |
12 |
|
chemoresistance |
12 |
|
colposcopy |
12 |
|
dna, neoplasm - genetics |
12 |
|
dysglycaemia |
12 |
|
endometrial cancer |
12 |
|
fallopian tubes - metabolism |
12 |
|
gene expression regulation |
12 |
|
in situ nick-end labeling |
12 |
|
magnetic resonance imaging |
12 |
|
mitochondria |
12 |
|
motility |
12 |
|
p53 |
12 |
|
phenotype |
12 |
|
placenta - metabolism |
12 |
|
reproducibility of results |
12 |
|
reproductive medicine |
12 |
|
rna, messenger - analysis |
12 |
|
spermatozoa - metabolism |
12 |
|
spermatozoa - physiology |
12 |
|
treatment outcome |
12 |
|
tumor markers, biological - analysis |
12 |
|
ultrasonography, prenatal |
12 |
|
beta catenin - metabolism |
11 |
|
biological markers - blood |
11 |
|
body weight |
11 |
|
brca1 protein - genetics |
11 |
|
cell adhesion molecules - genetics - metabolism |
11 |
|
chemokines |
11 |
|
cho cells - virology |
11 |
|
chorionic gonadotropin - blood |
11 |
|
chromosome aberrations |
11 |
|
chromosomes, human, pair 11 |
11 |
|
ciliary beat frequency |
11 |
|
coronavirus |
11 |
|
counseling |
11 |
|
cross-sectional studies |
11 |
|
differentiation |
11 |
|
disease progression |
11 |
|
dna primers |
11 |
|
dna-binding proteins - genetics - metabolism |
11 |
|
emergency contraception |
11 |
|
endometrial carcinoma |
11 |
|
endometriosis |
11 |
|
estrogen |
11 |
|
exons |
11 |
|
fatty liver disease |
11 |
|
female reproductive tract |
11 |
|
glycoproteins - metabolism |
11 |
|
hcg |
11 |
|
hpv |
11 |
|
in situ hybridization, fluorescence |
11 |
|
intestine, small - physiology |
11 |
|
lectins, c-type - genetics - metabolism |
11 |
|
lung - physiology - virology |
11 |
|
mafld (metabolic associated fatty liver disease) |
11 |
|
male infertility |
11 |
|
methylation |
11 |
|
obstetrics and gynecology medical sciences |
11 |
|
ovarian reserve |
11 |
|
overweight |
11 |
|
pd-l1 |
11 |
|
phosphorylation |
11 |
|
population based study |
11 |
|
prenatal diagnosis - methods |
11 |
|
proteasome endopeptidase complex - metabolism |
11 |
|
questionnaires |
11 |
|
receptors, cell surface - genetics - metabolism |
11 |
|
reference values |
11 |
|
reproduction |
11 |
|
sars coronavirus |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
sequence homology, amino acid |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
sperm motility |
11 |
|
tandem repeat sequences |
11 |
|
telomerase |
11 |
|
tissue distribution |
11 |
|
traditional chinese medicine |
11 |
|
twins |
11 |
|
vero cells - virology |
11 |
|
abortion, induced |
10 |
|
age factors |
10 |
|
aneuploidy |
10 |
|
blotting, northern |
10 |
|
bone mineral density |
10 |
|
carcinoma - genetics - pathology |
10 |
|
cervical cytology |
10 |
|
cesarean section |
10 |
|
chromosome deletion |
10 |
|
coculture techniques |
10 |
|
complications |
10 |
|
counselling |
10 |
|
cumulative live birth rate |
10 |
|
down syndrome |
10 |
|
down-regulation |
10 |
|
embryo transfer |
10 |
|
fertility |
10 |
|
follicle stimulating hormone - blood |
10 |
|
gene knockdown techniques |
10 |
|
human |
10 |
|
immunoenzyme techniques |
10 |
|
leiomyosarcoma |
10 |
|
mapk signaling |
10 |
|
maternal age |
10 |
|
mental health |
10 |
|
models, biological |
10 |
|
mtor |
10 |
|
oocyte |
10 |
|
ovarian carcinoma |
10 |
|
ovarian neoplasms - genetics - metabolism - pathology |
10 |
|
ovulation |
10 |
|
placebo |
10 |
|
probability |
10 |
|
qualitative |
10 |
|
sperm motility - drug effects |
10 |
|
spermatogenesis - physiology |
10 |
|
statistics, nonparametric |
10 |
|
ulipristal acetate |
10 |
|
uterine neoplasms - genetics - metabolism - pathology |
10 |
|
x chromosome |
10 |
|
apoptosis - drug effects |
9 |
|
azacitidine - analogs & derivatives - pharmacology |
9 |
|
breastfeeding |
9 |
|
caspases - metabolism |
9 |
|
cell signaling |
9 |
|
china - epidemiology |
9 |
|
chorionic villi |
9 |
|
contrast-enhanced ct |
9 |
|
cryopreservation |
9 |
|
depression |
9 |
|
dna, viral - genetics |
9 |
|
doppler |
9 |
|
drug resistance, neoplasm |
9 |
|
early pregnancy |
9 |
|
embryo development |
9 |
|
embryonic and fetal development - drug effects |
9 |
|
endometrial stem cells |
9 |
|
epithelial ovarian cancer |
9 |
|
erk |
9 |
|
estrogen receptors |
9 |
|
fallopian tubes - physiology |
9 |
|
foxm1 |
9 |
|
gene amplification |
9 |
|
gene expression regulation, developmental |
9 |
|
gestational diabetes mellitus |
9 |
|
glutathione peroxidase |
9 |
|
glycodelin |
9 |
|
human embryonic stem cells |
9 |
|
human trophoblast |
9 |
|
hyaluronic acid |
9 |
|
immortalization |
9 |
|
immunoblotting |
9 |
|
immunoprecipitation |
9 |
|
immunotherapy |
9 |
|
keratins - metabolism |
9 |
|
kidney |
9 |
|
levonorgestrel |
9 |
|
logistic models |
9 |
|
macrophage |
9 |
|
membrane proteins - genetics |
9 |
|
metformin |
9 |
|
muscular contraction |
9 |
|
neoplasm metastasis |
9 |
|
neoplasm, residual |
9 |
|
observer variation |
9 |
|
olfactomedin-1 |
9 |
|
ovarian neoplasms - genetics |
9 |
|
ovarian neoplasms - genetics - pathology |
9 |
|
oxidative stress - physiology |
9 |
|
papillomaviridae - genetics |
9 |
|
pedigree |
9 |
|
perfusion |
9 |
|
polymorphism, genetic |
9 |
|
polymorphism, genetic - genetics |
9 |
|
pregnancy complications |
9 |
|
protein structure, tertiary |
9 |
|
proteins - genetics - metabolism |
9 |
|
pten |
9 |
|
radioimmunoassay |
9 |
|
sex factors |
9 |
|
social support |
9 |
|
superoxide dismutase |
9 |
|
suppression subtractive hybridization |
9 |
|
survival |
9 |
|
survival analysis |
9 |
|
thalassaemia |
9 |
|
tumor markers, biological - metabolism |
9 |
|
ubiquitin - metabolism |
9 |
|
vagina |
9 |
|
wnt-signaling |
9 |
|
young adult |
9 |
|
abortion |
8 |
|
acrosome |
8 |
|
adenocarcinoma |
8 |
|
adrenomedullin - genetics - metabolism |
8 |
|
age |
8 |
|
alzheimer's disease |
8 |
|
analysis of variance |
8 |
|
angiogenesis |
8 |
|
antioxidant activity |
8 |
|
application |
8 |
|
appswe/ps1de9 |
8 |
|
aquaporin 9 |
8 |
|
ascitic fluid |
8 |
|
assisted reproduction |
8 |
|
autophagy |
8 |
|
baby-friendly hospital initiative |
8 |
|
beta-amyloid |
8 |
|
blotting, southern |
8 |
|
calcitonin receptor-like protein |
8 |
|
capacitation |
8 |
|
carcinoma/metabolism |
8 |
|
carcinoma/secondary |
8 |
|
cd147 |
8 |
|
cell adhesion |
8 |
|
cell communication - physiology |
8 |
|
cell division - drug effects |
8 |
|
cell movement |
8 |
|
cell nucleus - metabolism |
8 |
|
choriocarcinoma - genetics |
8 |
|
choriocarcinoma - genetics - pathology |
8 |
|
cilia - metabolism - physiology |
8 |
|
cloning, molecular |
8 |
|
community |
8 |
|
comparative genomic hybridization |
8 |
|
decidualization |
8 |
|
dna hypermethylation |
8 |
|
dna primers - genetics |
8 |
|
dna, neoplasm - blood - genetics |
8 |
|
embryo culture techniques |
8 |
|
endocrinology pharmacy and pharmacology |
8 |
|
epithelium - metabolism - physiology |
8 |
|
estradiol - blood |
8 |
|
estrogen receptor alpha - genetics - metabolism |
8 |
|
fertility preservation |
8 |
|
follow-up |
8 |
|
founder effect |
8 |
|
frozen-thawed embryo transfer |
8 |
|
gene deletion |
8 |
|
gene expression regulation - drug effects |
8 |
|
genes, p53 - genetics |
8 |
|
genetic predisposition to disease - genetics |
8 |
|
gestational diabetes |
8 |
|
gli1 |
8 |
|
glycoprotein |
8 |
|
glycoproteins - physiology |
8 |
|
glycosylation |
8 |
|
hescs |
8 |
|
hormones - metabolism - pharmacology |
8 |
|
human embryonic stem cell |
8 |
|
hydatidiform mole - genetics |
8 |
|
hydatidiform mole - genetics - pathology |
8 |
|
hyperglycemia |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
intrauterine insemination |
8 |
|
kidney - cytology |
8 |
|
letrozole |
8 |
|
live birth rate |
8 |
|
management |
8 |
|
menstrual cycle |
8 |
|
menstrual cycle - genetics - metabolism - physiology |
8 |
|
metabolic syndrome |
8 |
|
mice, inbred balb c |
8 |
|
notch |
8 |
|
nuchal translucency |
8 |
|
nuclear proteins - genetics - metabolism |
8 |
|
oligonucleotide array sequence analysis |
8 |
|
oral glucose tolerance test |
8 |
|
ovarian neoplasms |
8 |
|
ovarian stimulation |
8 |
|
pet/ct |
8 |
|
phenotyping |
8 |
|
pilot projects |
8 |
|
polymorphism, restriction fragment length |
8 |
|
pregnancy proteins - metabolism |
8 |
|
prenatal exome |
8 |
|
prognostic marker |
8 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
8 |
|
rct |
8 |
|
receptor activity-modifying proteins |
8 |
|
receptors, calcitonin - genetics - metabolism |
8 |
|
rna, messenger - biosynthesis - genetics |
8 |
|
rna, neoplasm - analysis |
8 |
|
rna, ribosomal, 16s - genetics |
8 |
|
sars-cov-2 |
8 |
|
self-renewal |
8 |
|
sp1 |
8 |
|
spermatozoa - metabolism - physiology |
8 |
|
squamous cell carcinoma |
8 |
|
squamous intraepithelial lesion |
8 |
|
stakeholders |
8 |
|
stem cell |
8 |
|
stem cells |
8 |
|
stimulated cycles |
8 |
|
subfertility |
8 |
|
targeted therapy |
8 |
|
testis - cytology - physiology |
8 |
|
testis - metabolism |
8 |
|
testosterone |
8 |
|
trophoblastic neoplasms - metabolism - pathology |
8 |
|
up-regulation |
8 |
|
uterine neoplasms - genetics - pathology |
8 |
|
uterine neoplasms - metabolism - pathology |
8 |
|
variants of unknown clinical significance |
8 |
|
wnt signaling |
8 |
|
-depression |
7 |
|
acrosome - physiology |
7 |
|
acrosome reaction - drug effects - physiology |
7 |
|
acupuncture |
7 |
|
adaptor proteins, signal transducing - genetics - metabolism |
7 |
|
age‐specific reference range |
7 |
|
aging |
7 |
|
analgesia |
7 |
|
antigens, neoplasm |
7 |
|
antimetabolites, antineoplastic - pharmacology |
7 |
|
anti‐müllerian hormone |
7 |
|
anxiety |
7 |
|
assisted reproductive technology |
7 |
|
attachment |
7 |
|
attitude |
7 |
|
automated chemiluminescence assay |
7 |
|
baby-friendly |
7 |
|
baby-friendly community initiative |
7 |
|
baby-friendly initiative |
7 |
|
beta-thalassemia - diagnosis - genetics |
7 |
|
bioactive compounds |
7 |
|
biochemistry |
7 |
|
biopsy, needle |
7 |
|
bone density |
7 |
|
breast neoplasms - epidemiology - genetics |
7 |
|
cancer stem cells |
7 |
|
cancer-related distress |
7 |
|
cell culture techniques - methods |
7 |
|
cell cycle proteins - analysis |
7 |
|
cell fate determination |
7 |
|
cervix uteri - virology |
7 |
|
choriocarcinoma - genetics - metabolism - pathology |
7 |
|
chorionic gonadotropin, beta subunit, human - blood |
7 |
|
chromosomes, human, pair 17 |
7 |
|
cisplatin - pharmacology |
7 |
|
colorectal cancer |
7 |
|
confidence intervals |
7 |
|
cord blood transplantation |
7 |
|
cp: developmental biology |
7 |
|
cytoreduction |
7 |
|
dalys |
7 |
|
diagnostic biomarker |
7 |
|
diffusion magnetic resonance imaging |
7 |
|
distress |
7 |
|
dna, mitochondrial - genetics |
7 |
|
dna, neoplasm |
7 |
|
dna-binding proteins |
7 |
|
e-cadherin |
7 |
|
ehealth |
7 |
|
embryotrophic factor |
7 |
|
endometrial regeneration |
7 |
|
epithelioid |
7 |
|
epsc |
7 |
|
estradiol |
7 |
|
estradiol - pharmacology |
7 |
|
estrogen receptors (ers) |
7 |
|
expanded potential stem cell |
7 |
|
extraction |
7 |
|
extravillous trophoblast |
7 |
|
fallopian tubes |
7 |
|
fluorescent antibody technique |
7 |
|
follicle-stimulating hormone |
7 |
|
friendly communities |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
genes, brca1 |
7 |
|
genes, brca2 |
7 |
|
genetics |
7 |
|
genital neoplasms, female - metabolism - pathology |
7 |
|
gestational |
7 |
|
gestational trophoblastic disease - metabolism - pathology |
7 |
|
globins - genetics |
7 |
|
graft survival |
7 |
|
health economic analysis |
7 |
|
health literacy |
7 |
|
health-related quality of life |
7 |
|
hedgehog |
7 |
|
hepatocellular carcinoma |
7 |
|
heterozygote |
7 |
|
hkuot-s2 protein |
7 |
|
hpv vaccination |
7 |
|
human chorionic gonadotrophin |
7 |
|
human expanded potential stem cells |
7 |
|
hydatidiform mole - metabolism - pathology |
7 |
|
hydrogen-ion concentration |
7 |
|
hysteroscopy |
7 |
|
iaspp |
7 |
|
illness perception |
7 |
|
in-vitro fertilization |
7 |
|
incidence |
7 |
|
infection |
7 |
|
inflammatory cytokines |
7 |
|
insomnia |
7 |
|
ki-67 antigen - analysis |
7 |
|
ki67 |
7 |
|
long-term cancer survivors |
7 |
|
loss of heterozygosity |
7 |
|
lrp5 |
7 |
|
mass spectrometry |
7 |
|
meta-analysis |
7 |
|
metastasis |
7 |
|
mhealth |
7 |
|
microsatellite repeats |
7 |
|
mobile app |
7 |
|
molar pregnancy |
7 |
|
morphine consumption |
7 |
|
mother |
7 |
|
multiple reaction monitoring |
7 |
|
nasal ciliated epithelium |
7 |
|
neoadjuvant chemotherapy |
7 |
|
neoplasm recurrence, local |
7 |
|
nuclear proteins |
7 |
|
occupation |
7 |
|
oligonucleotide array sequence analysis - methods |
7 |
|
oocyte retrieval |
7 |
|
oocytes - physiology |
7 |
|
oogenesis |
7 |
|
organ specificity |
7 |
|
osteoblast functions |
7 |
|
outcome assessment (health care) |
7 |
|
ovarian clear cell carcinoma |
7 |
|
ovarian neoplasms - metabolism - pathology |
7 |
|
ovarian sensitivity index |
7 |
|
ovariectomy |
7 |
|
ovariectomy (ovx) |
7 |
|
ovary - pathology |
7 |
|
oviductal epithelial cell |
7 |
|
pain relief |
7 |
|
patient acceptance of health care |
7 |
|
pcr |
7 |
|
placentation |
7 |
|
plk1 |
7 |
|
poor ovarian response |
7 |
|
pregnancy - blood |
7 |
|
pregnancy outcomes |
7 |
|
pregnancy trimester, second |
7 |
|
preimplantation embryo |
7 |
|
preimplantation embryo development |
7 |
|
prenatal screening |
7 |
|
proteomics |
7 |
|
psychological well-being |
7 |
|
randomized controlled trial |
7 |
|
real-time polymerase chain reaction |
7 |
|
repressor proteins - biosynthesis |
7 |
|
return to work |
7 |
|
second trimester |
7 |
|
self-management |
7 |
|
self-sampling |
7 |
|
sequence alignment |
7 |
|
sequence deletion |
7 |
|
serms |
7 |
|
sex education |
7 |
|
sexual health |
7 |
|
signal transduction - drug effects |
7 |
|
sleep disturbance |
7 |
|
sleep quality |
7 |
|
sleep trajectory |
7 |
|
somatic mutations |
7 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
7 |
|
spermatozoa - chemistry |
7 |
|
spermatozoa - cytology - metabolism |
7 |
|
t cell |
7 |
|
t cells |
7 |
|
telomerase - metabolism |
7 |
|
testis - physiology |
7 |
|
transcription factors - genetics |
7 |
|
transcription factors - genetics - metabolism |
7 |
|
trophoblast lineage |
7 |
|
trophoblast organoid |
7 |
|
trophoblast stem cell |
7 |
|
trophoblastic |
7 |
|
tumor suppressor protein p53 |
7 |
|
tumor suppressor protein p53 - analysis |
7 |
|
tumors |
7 |
|
tumor‐shrinking decoction |
7 |
|
ultrasonography, prenatal - methods |
7 |
|
ultra‐pressure liquid chromatography coupled tandem mass spectrometry |
7 |
|
user-friendly |
7 |
|
uterine cervical neoplasms |
7 |
|
uterine neoplasms |
7 |
|
vaginal smears |
7 |
|
viral load |
7 |
|
well-being |
7 |
|
wnt proteins - physiology |
7 |
|
women's health |
7 |
|
work productivity |
7 |
|
y chromosome |
7 |
|
zinc fingers |
7 |
|
zona pellucida binding |
7 |
|
3d ultrasound |
6 |
|
5-fluorouracil |
6 |
|
acrosome - metabolism |
6 |
|
adenocarcinoma - genetics - metabolism - pathology |
6 |
|
administration, oral |
6 |
|
adult oncology |
6 |
|
advanced glycation end-products |
6 |
|
alpha-macroglobulins - metabolism |
6 |
|
antioxidants - analysis - metabolism |
6 |
|
anxiety - etiology |
6 |
|
apoptosis - drug effects - physiology |
6 |
|
apoptosis - physiology |
6 |
|
aquaporin-5 |
6 |
|
arctium - chemistry - genetics - metabolism |
6 |
|
art |
6 |
|
asian women |
6 |
|
b cells |
6 |
|
basigin |
6 |
|
binding sites |
6 |
|
blotting, western - methods |
6 |
|
bmd |
6 |
|
body mass index |
6 |
|
bone defect repair |
6 |
|
bone density - genetics |
6 |
|
bone mineral density (bmd) |
6 |
|
brca1 |
6 |
|
burdock |
6 |
|
c-mos |
6 |
|
cadherins - genetics - metabolism |
6 |
|
caffeoylquinic acids |
6 |
|
calcium-calmodulin-dependent protein kinases - genetics |
6 |
|
carcinogenesis |
6 |
|
carcinoma, hepatocellular - metabolism - pathology |
6 |
|
carcinoma, squamous cell - genetics |
6 |
|
carcinoma, squamous cell - genetics - virology |
6 |
|
cell adhesion - physiology |
6 |
|
cell biology |
6 |
|
cell count |
6 |
|
cell differentiation |
6 |
|
cell differentiation - physiology |
6 |
|
cell migration |
6 |
|
cell transformation, neoplastic - genetics |
6 |
|
cell-signaling pathways |
6 |
|
cervix |
6 |
|
checkpoint inhibitor |
6 |
|
chemical constituent |
6 |
|
chimera |
6 |
|
chinese herbal medicine |
6 |
|
chromatography, liquid |
6 |
|
chromosome in situ hybridization |
6 |
|
chronic obstructive pulmonary disease |
6 |
|
cin |
6 |
|
combined modality therapy |
6 |
|
conscious sedation |
6 |
|
consensus sequence |
6 |
|
co‐testing |
6 |
|
cpg islands |
6 |
|
culture techniques |
6 |
|
cumulus cells - metabolism |
6 |
|
cumulus matrix |
6 |
|
cyclin-dependent kinase inhibitor p21 |
6 |
|
cytokine |
6 |
|
cytotoxic activity |
6 |
|
dce-mri |
6 |
|
dendrobium officinale polysaccharides |
6 |
|
diastole |
6 |
|
diet therapy |
6 |
|
differential gene expression |
6 |
|
diffusion-weighted imaging |
6 |
|
dioscorea spp protein |
6 |
|
disease models, animal |
6 |
|
dna damage |
6 |
|
dna modification methylases - antagonists & inhibitors |
6 |
|
down syndrome - blood |
6 |
|
down's syndrome |
6 |
|
dual specificity phosphatase 6 - antagonists & inhibitors - genetics - metabolism |
6 |
|
early development |
6 |
|
education |
6 |
|
eg-vegf |
6 |
|
embryo attachment |
6 |
|
embryonic stem cells - cytology - metabolism - physiology |
6 |
|
endometrial neoplasms - genetics - metabolism |
6 |
|
endometrium - metabolism |
6 |
|
endometrium - pathology |
6 |
|
environment |
6 |
|
epigenesis, genetic |
6 |
|
epithelial cells - pathology |
6 |
|
erxian decoction |
6 |
|
evaluation studies as topic |
6 |
|
extracellular matrix - physiology |
6 |
|
extracellular matrix proteins - metabolism |
6 |
|
extracellular matrix proteins - physiology |
6 |
|
fallopian tubes - cytology |
6 |
|
fallopian tubes - cytology - metabolism |
6 |
|
fasting glucose |
6 |
|
feeder cell |
6 |
|
fetal blood |
6 |
|
fibroblasts - cytology - metabolism - physiology |
6 |
|
foreskin - cytology |
6 |
|
gene expression - drug effects |
6 |
|
gene expression regulation, neoplastic - drug effects |
6 |
|
gene library |
6 |
|
genes, p53 |
6 |
|
genes, reporter |
6 |
|
genetic linkage |
6 |
|
genetics, population |
6 |
|
genital neoplasms, female - genetics |
6 |
|
germ cell tumor |
6 |
|
gleditsia sinensis |
6 |
|
glycodelin-a |
6 |
|
golgi apparatus |
6 |
|
growth factor |
6 |
|
gynaecological cancer |
6 |
|
gynecological cancer |
6 |
|
gynecological neoplasm |
6 |
|
health knowledge, attitudes, practice |
6 |
|
hedgehog proteins - genetics - metabolism |
6 |
|
helix-loop-helix motifs |
6 |
|
high-grade tumor |
6 |
|
hippo signaling |
6 |
|
hpv testing |
6 |
|
hpv16/18 genotyping |
6 |
|
ht-29 cells |
6 |
|
human endometrium |
6 |
|
hyaluronic acid - metabolism |
6 |
|
hydrogen peroxide - metabolism |
6 |
|
hydrosalpinx fluid |
6 |
|
hydroxamic acids - pharmacology |
6 |
|
id proteins |
6 |
|
imaging, three-dimensional |
6 |
|
implantation rate |
6 |
|
in vitro implantation model |
6 |
|
infants |
6 |
|
infertility, male - genetics |
6 |
|
inflammation |
6 |
|
inhibins - blood |
6 |
|
inhibitor of differentiation protein 1 |
6 |
|
injections, intramuscular |
6 |
|
intestinal mucositis |
6 |
|
intracellular signaling peptides and proteins |
6 |
|
intracytoplasmic sperm injection |
6 |
|
ivim |
6 |
|
japan |
6 |
|
laparotomy |
6 |
|
lc-ms |
6 |
|
ldl-receptor related proteins - genetics |
6 |
|
leguminosae |
6 |
|
leptin |
6 |
|
leptin receptor |
6 |
|
lignans |
6 |
|
lignans - analysis - metabolism |
6 |
|
linear models |
6 |
|
linkage |
6 |
|
liver - metabolism |
6 |
|
liver neoplasms - metabolism - pathology |
6 |
|
low density lipoprotein receptor-related protein-5 |
6 |
|
lung - cytology |
6 |
|
luteinizing hormone - blood |
6 |
|
lymphadenectomy |
6 |
|
lymphoma |
6 |
|
maldi-qit-tof ms |
6 |
|
male reproductive tract |
6 |
|
malignant ovarian germ cell tumors |
6 |
|
maps |
6 |
|
mass screening - methods |
6 |
|
maternal immune tolerance |
6 |
|
matrix metalloproteinase |
6 |
|
medical abortion |
6 |
|
medical records |
6 |
|
meiosis |
6 |
|
menorrhagia |
6 |
|
menotropins - therapeutic use |
6 |
|
mesenchymal stem cells (mscs) |
6 |
|
mesocricetus |
6 |
|
metallothionein - genetics - metabolism |
6 |
|
metallothionein 1e gene |
6 |
|
microdissection |
6 |
|
micrornas - genetics - metabolism |
6 |
|
microsatellite repeats - genetics |
6 |
|
mir-141 |
6 |
|
mitogen-activated protein kinase 1 - antagonists & inhibitors - metabolism |
6 |
|
mitogen-activated protein kinase 3 - antagonists & inhibitors - metabolism |
6 |
|
morphology |
6 |
|
mtor signaling pathway |
6 |
|
mucin-5ac |
6 |
|
multivariate analysis |
6 |
|
neoplasm proteins - genetics |
6 |
|
neoplasm proteins - genetics - metabolism |
6 |
|
neoplasms |
6 |
|
nf-κb signaling |
6 |
|
nih 3t3 cells |
6 |
|
nuclear proteins - genetics |
6 |
|
odds ratio |
6 |
|
organ size |
6 |
|
osteoblast differentiation |
6 |
|
osteoblasts - metabolism |
6 |
|
osteoporosis - genetics - metabolism |
6 |
|
ovarian neoplasms - drug therapy - genetics - pathology |
6 |
|
ovarian neoplasms - drug therapy - pathology |
6 |
|
ovarian neoplasms - pathology |
6 |
|
ovulation induction - methods |
6 |
|
p-pkb |
6 |
|
p63 |
6 |
|
papillomavirus infections - diagnosis - virology |
6 |
|
papillomavirus infections - epidemiology - ethnology - virology |
6 |
|
papillomavirus vaccines |
6 |
|
papp-a |
6 |
|
pax1/sox1 methylation |
6 |
|
pdk1 |
6 |
|
pkr1 |
6 |
|
pkr2 |
6 |
|
placenta - chemistry |
6 |
|
placenta - metabolism - pathology |
6 |
|
plant extracts - analysis - metabolism |
6 |
|
plant roots - chemistry - genetics - metabolism |
6 |
|
ploidies |
6 |
|
pomegranate peel ellagitannins |
6 |
|
postpartum |
6 |
|
preeclampsia |
6 |
|
pregnancy trimester, first - blood |
6 |
|
pregnancy, tubal - physiopathology |
6 |
|
preimplantation diagnosis |
6 |
|
preimplantation genetic testing |
6 |
|
premature ovarian failure |
6 |
|
progesterone receptor |
6 |
|
promoter hypermethylation |
6 |
|
protein isoforms - metabolism |
6 |
|
proteins - chemistry - genetics - metabolism |
6 |
|
proteins - genetics |
6 |
|
proto-oncogene proteins - genetics - metabolism |
6 |
|
proto-oncogene proteins c-mos - biosynthesis |
6 |
|
quinic acid - analogs & derivatives - analysis - metabolism |
6 |
|
reliability |
6 |
|
repressor proteins - metabolism |
6 |
|
reverse transcriptase polymerase chain reaction - methods |
6 |
|
rickets |
6 |
|
risk assessment |
6 |
|
rna, messenger - antagonists & inhibitors - genetics - metabolism |
6 |
|
roots |
6 |
|
seeds |
6 |
|
seeds - chemistry - genetics - metabolism |
6 |
|
sermatogenesis |
6 |
|
serum 25-hydroxyvitamin d |
6 |
|
soluble receptor of advanced glycation end-products |
6 |
|
sperm fucosyltransferase-5 |
6 |
|
sperm injections, intracytoplasmic |
6 |
|
spermatogenesis - genetics |
6 |
|
spermatozoa - drug effects - physiology |
6 |
|
stem cell-microenvironment interactions |
6 |
|
steroid hormones |
6 |
|
steroid receptors |
6 |
|
steroidogenic |
6 |
|
stromal cells |
6 |
|
structural identification |
6 |
|
survival rate |
6 |
|
syntaxin |
6 |
|
tak1 |
6 |
|
tcdd |
6 |
|
testosterone - blood |
6 |
|
therapeutic irrigation |
6 |
|
threatened miscarriage |
6 |
|
three-dimensional ultrasound |
6 |
|
tight junction |
6 |
|
transcription factors - biosynthesis |
6 |
|
transforming growth factor alpha - deficiency - metabolism |
6 |
|
transforming growth factor beta - genetics |
6 |
|
transforming growth factor beta1 |
6 |
|
transforming growth factor α |
6 |
|
triage |
6 |
|
trophoblastic spheroids |
6 |
|
trophoblastic tumor |
6 |
|
trophoblastic tumor, placental site - genetics - metabolism - pathology |
6 |
|
trophoblasts |
6 |
|
trophoblasts - chemistry - pathology |
6 |
|
tumor microenvironment |
6 |
|
tumor suppressor proteins |
6 |
|
tumourigenicity |
6 |
|
turner's syndrome |
6 |
|
ubiquitination |
6 |
|
ultrasonography, doppler, color |
6 |
|
urokinase plasminogen activator |
6 |
|
uterine cervical neoplasms - genetics |
6 |
|
uterine cervical neoplasms - genetics - metabolism - pathology |
6 |
|
uterine cervical neoplasms - pathology |
6 |
|
uterine cervix |
6 |
|
utmvec-myo |
6 |
|
vaginal bleeding |
6 |
|
validity |
6 |
|
vulvar neoplasms - genetics - virology |
6 |
|
wnt |
6 |
|
wnt/β-catenin signaling |
6 |
|
zic2 |
6 |
|
α2-macroglobulin |
6 |
|
β-actin |
6 |
|
25-hydroxyvitamin d |
5 |
|
abdominal pregnancy |
5 |
|
acquired chemoresistance |
5 |
|
actinomyces - classification - cytology - isolation & purification - physiology |
5 |
|
actinomyces hongkongensis |
5 |
|
actinomycosis - microbiology |
5 |
|
active components |
5 |
|
acute disease |
5 |
|
adenocarcinoma, clear cell - genetics - metabolism - pathology |
5 |
|
adenomyosis |
5 |
|
adiposity |
5 |
|
advanced ovarian cancer |
5 |
|
akt |
5 |
|
alpha-thalassemia - diagnosis - genetics |
5 |
|
amniotic fluid |
5 |
|
amniotic fluid - chemistry |
5 |
|
amniotic fluid - metabolism |
5 |
|
anaerobiosis |
5 |
|
androgen |
5 |
|
angiopoietin |
5 |
|
animal experiment |
5 |
|
animal model |
5 |
|
anoikis resistance |
5 |
|
anti-mullerian hormone - blood |
5 |
|
antibody |
5 |
|
antigens, cd - genetics - metabolism |
5 |
|
antigens, differentiation, myelomonocytic - genetics - metabolism |
5 |
|
antigens, polyomavirus transforming - genetics |
5 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
5 |
|
antineoplastic-agents-pharmacology |
5 |
|
anti‐mullerian hormone |
5 |
|
aorta |
5 |
|
apoptosis regulatory proteins |
5 |
|
apoptosis regulatory proteins - genetics - metabolism |
5 |
|
aquaporin 1 - metabolism |
5 |
|
aquaporin 2 - metabolism |
5 |
|
aquaporin 5 |
5 |
|
aquaporins |
5 |
|
ascites |
5 |
|
bacterial typing techniques |
5 |
|
beta-thalassemia - blood - immunology - therapy |
5 |
|
bioavailability |
5 |
|
biochemical profile |
5 |
|
biological markers - analysis |
5 |
|
birth control |
5 |